MicroVue™ C4a EIA A035 from QuidelOrtho

Product Specs
ItemMicroVue™ C4a EIA
CompanyQuidelOrtho
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberA035
StorageStore the unopened kit at 2°C to 8°C. Refer to Product Insert for additional storage details
Regulatory StatusFor Research Use Only in the United States. Not for use in diagnostic procedures
Format96 well plate with 12 eight-well strips in a resealable foil pouch
Quantity96 wells/test
ReactivityAfrican Green Monkey, Cynomolgous monkey, Rhesus monkey
ApplicationsELISA
Sample TypeSerum/EDTA Plasma 10 µL
Assay Time2.5 hours

9975 Summers Ridge Road

San Diego 92121

United States

Phone: (+1) 858 552 1100

(1) Comparison of Complement Pathway Activation in Autoimmune GlomerulonephritisKidney international reportsMay 1, 2022Genest DS, Bonnefoy A, Khalili M, Merlen C, Genest G, Lapeyraque AL, Patey N, Smail N, Royal V, Troyanov S.

(2) Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole BloodJournal of immunology (Baltimore, Md. : 1950)December 1, 2021Storm BS, Christiansen D, Fure H, Ludviksen JK, Lau C, Lambris JD, Woodruff TM, Brekke OL, Braaten T, Nielsen EW, et al.

(3) Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritisClinical rheumatologyJune 1, 2021Mejia-Vilet JM, Gómez-Ruiz IA, Cruz C, Méndez-Pérez RA, Comunidad-Bonilla RA, Uribe-Uribe NO, Nuñez-Alvarez CA, Morales-Buenrostro LE.

(5) Complement fragments are biomarkers of antibody-mediated endothelial injuryMolecular immunologyFebruary 1, 2020Stites E, Renner B, Laskowski J, Le Quintrec M, You Z, Freed B, Cooper J, Jalal D, Thurman JM.

(6) Subvisible Particles in IVIg Formulations Activate Complement in Human SerumJournal of pharmaceutical sciencesJanuary 1, 2020Chisholm CF, Behnke W, Pokhilchuk Y, Frazer-Abel AA, Randolph TW.

(7) Clinical Value of Complement Activation Biomarkers in Overt Diabetic NephropathyKidney international reportsJune 1, 2019Pelletier K, Bonnefoy A, Chapdelaine H, Pichette V, Lejars M, Madore F, Brachemi S, Troyanov S.

(8) C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos SyndromeFrontiers in immunologyJanuary 1, 2019Gröbner R, Kapferer-Seebacher I, Amberger A, Redolfi R, Dalonneau F, Björck E, Milnes D, Bally I, Rossi V, Thielens N, et al.

(9) rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRsJournal of immunology (Baltimore, Md. : 1950)April 15, 2018Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, et al.

(10) Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attackAllergyFebruary 1, 2018Veszeli N, Kőhalmi KV, Kajdácsi E, Gulyás D, Temesszentandrási G, Cervenak L, Farkas H, Varga L.

(11) Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex FormationPloS oneJanuary 1, 2016Chan AS, Jonas AB, Qiu X, Ottoson NR, Walsh RM, Gorden KB, Harrison B, Maimonis PJ, Leonardo SM, Ertelt KE, et al.

(13) Complement activation in patients with neuromyelitis opticaJournal of neuroimmunologySeptember 15, 2014Nytrova P, Potlukova E, Kemlink D, Woodhall M, Horakova D, Waters P, Havrdova E, Zivorova D, Vincent A, Trendelenburg M.

(14) Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular healthInvestigative ophthalmology & visual scienceMay 22, 2014Owsley C, Huisingh C, Jackson GR, Curcio CA, Szalai AJ, Dashti N, Clark M, Rookard K, McCrory MA, Wright TT, et al.

(15) Complement activation in pediatric patients with recurrent acute otitis mediaInternational journal of pediatric otorhinolaryngologyJune 1, 2013He Y, Scholes MA, Wiet GJ, Li Q, Clancy C, Tong HH.

(16) Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-DependentFrontiers in immunologyJanuary 1, 2013Bose N, Chan AS, Guerrero F, Maristany CM, Qiu X, Walsh RM, Ertelt KE, Jonas AB, Gorden KB, Dudney CM, et al.

(17) Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotideInternational immunopharmacologyNovember 1, 2002Henry SP, Beattie G, Yeh G, Chappel A, Giclas P, Mortari A, Jagels MA, Kornbrust DJ, Levin AA.

MicroVue™ C4a EIA from QuidelOrtho